Search research articles
Contact Us
Filters
Showing results (111-120 of 125) with videos related to
Page
of 13
Sort By:
Rheumatology (Oxford, England)
|
March 24, 2023
Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study
Satoshi Omura, Takashi Kida, Hisashi Noma, et al.
Clinical and Experimental Rheumatology
|
November 13, 2025
Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS)
Nakako Tanaka-Mabuchi, Takashi Kida, Shunichiro Hanai, et al.
Immunological Medicine
|
January 11, 2025
Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study
Chie Ogita, Kazuteru Noguchi, Jiro Takeuchi, et al.
Modern Rheumatology
|
February 19, 2026
Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicenter cohort study (J-CANVAS)
Motoki Takeuchi, Yoshiyuki Abe, Ayako Makiyama, et al.
Arthritis Research & Therapy
|
August 23, 2022
Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)
Yasuhiro Shimojima, Dai Kishida, Takanori Ichikawa, et al.
Modern Rheumatology
|
October 10, 2025
Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVAS
Satoshi Omura, Takashi Kida, Junya Kitai, et al.
Rheumatology International
|
November 12, 2025
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)
Genki Kidoguchi, Yusuke Yoshida, Satoshi Omura, et al.
Clinical Rheumatology
|
August 12, 2024
Effectiveness and safety of rituximab in severely relapsed antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis of a Japanese multicentre cohort from the J-CANVAS
Genki Kidoguchi, Yusuke Yoshida, Hirofumi Watanabe, et al.
International Journal of Rheumatic Diseases
|
February 11, 2026
Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVAS
Satoshi Omura, Takashi Kida, Hironori Inoue, et al.
Modern Rheumatology
|
October 6, 2023
Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVAS
Hideaki Sofue, Takashi Kida, Aiko Hirano, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 125) with videos related to
Sort By:
Page
of 13
Rheumatology (Oxford, England)
|
March 24, 2023
Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study
Satoshi Omura, Takashi Kida, Hisashi Noma, et al.
Clinical and Experimental Rheumatology
|
November 13, 2025
Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS)
Nakako Tanaka-Mabuchi, Takashi Kida, Shunichiro Hanai, et al.
Immunological Medicine
|
January 11, 2025
Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study
Chie Ogita, Kazuteru Noguchi, Jiro Takeuchi, et al.
Modern Rheumatology
|
February 19, 2026
Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicenter cohort study (J-CANVAS)
Motoki Takeuchi, Yoshiyuki Abe, Ayako Makiyama, et al.
Arthritis Research & Therapy
|
August 23, 2022
Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS)
Yasuhiro Shimojima, Dai Kishida, Takanori Ichikawa, et al.
Modern Rheumatology
|
October 10, 2025
Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVAS
Satoshi Omura, Takashi Kida, Junya Kitai, et al.
Rheumatology International
|
November 12, 2025
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)
Genki Kidoguchi, Yusuke Yoshida, Satoshi Omura, et al.
Clinical Rheumatology
|
August 12, 2024
Effectiveness and safety of rituximab in severely relapsed antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis of a Japanese multicentre cohort from the J-CANVAS
Genki Kidoguchi, Yusuke Yoshida, Hirofumi Watanabe, et al.
International Journal of Rheumatic Diseases
|
February 11, 2026
Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVAS
Satoshi Omura, Takashi Kida, Hironori Inoue, et al.
Modern Rheumatology
|
October 6, 2023
Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVAS
Hideaki Sofue, Takashi Kida, Aiko Hirano, et al.
Page
of 13